Hyoscine Butylbromide

3 trials 2 recruiting AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

3 Countries

Phase III

Phase III: 3

Indications tested

Prostate cancer 1

Sponsors using this IMP

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Oslo University Hospital HF 1 Region Vaesterbotten 1 Umea University 1

All trials

3 total

The effect of [18F]F-FAPI PET-CT on management in patients with potentially resectable biliary tract cancers: prospective multicenter study … Recruiting

2023-507938-24-00 Phase III 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Evaluation of PSMA-PET and mpMRI in high-risk prostate cancer – using histopathologic validation Recruiting

2022-501892-14-00 Phase III 1 country Region Vasterbotten; Umea University
A double-blind randomized placebo-controlled four-arm trial to assess the efficacy of oral bicarbonate and intravenous butylscopolamine brom… Ended

2024-511848-55-00 Phase III 1 country Oslo University Hospital HF

Showing 1–3 of 3 trials

← All drugs A–Z